Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?

Thomas M, Pavord I.

Prim Care Respir J. 2012 Mar;21(1):8-10. doi: 10.4104/pcrj.2012.00022. No abstract available.

2.

[Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].

Korn S, Vogelmeier C, Buhl R.

Med Klin (Munich). 2008 May 15;103(5):299-310. doi: 10.1007/s00063-008-1050-y. Review. German.

PMID:
18484216
3.

Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials.

Edwards SJ, von Maltzahn R, Naya IP, Harrison T.

Int J Clin Pract. 2010 Apr;64(5):619-27. doi: 10.1111/j.1742-1241.2009.02320.x. Review.

PMID:
20456215
4.

Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.

McCormack PL, Lyseng-Williamson KA.

Drugs. 2007;67(16):2407-31. Review.

PMID:
17983258
5.

Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control.

Riemersma RA, Postma D, van der Molen T.

Prim Care Respir J. 2012 Mar;21(1):50-6. doi: 10.4104/pcrj.2011.00090.

6.

A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.

Quirce S, Barcina C, Plaza V, Calvo E, Muñoz M, Ampudia R, Capel M.

J Asthma. 2011 Oct;48(8):839-47. doi: 10.3109/02770903.2011.611954. Erratum in: J Asthma. 2012 Aug;49(6):663.

PMID:
21942354
8.

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.

Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R; SMART Study Group.

Lancet Respir Med. 2013 Mar;1(1):32-42. doi: 10.1016/S2213-2600(13)70007-9. Epub 2013 Mar 4.

PMID:
24321802
9.
10.

Budesonide/formoterol (Symbicort) for asthma.

[No authors listed]

Med Lett Drugs Ther. 2008 Feb 11;50(1279):9-11. No abstract available.

PMID:
18264031
11.

Availability of the combination of formoterol and budesonide in the United States of America.

Blango CM, O'Brien CD.

Allergy Asthma Proc. 2008 Jul-Aug;29(4):426. doi: 10.2500/aap.2008.29.3130. No abstract available.

PMID:
18702893
13.

["Real-life"-data on asthma control using budesonide/formoterol for both maintenance and relief: the Swiss experience].

Steurer-Stey C, Courteheuse C, Taegtmeyer AB, Leuppi JD.

Praxis (Bern 1994). 2009 Nov 18;98(23):1335-42. doi: 10.1024/1661-8157.98.23.1335. German.

PMID:
19918725
14.

Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Vogelmeier C, Naya I, Ekelund J.

Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.

PMID:
22607479
15.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kew KM, Karner C, Mindus SM, Ferrara G.

Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019. doi: 10.1002/14651858.CD009019.pub2. Review.

PMID:
24343671
16.

Management of severe asthma in children.

Bush A, Saglani S.

Lancet. 2010 Sep 4;376(9743):814-25. doi: 10.1016/S0140-6736(10)61054-9. Review.

17.

Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.

Bisgaard H, Le Roux P, Bjåmer D, Dymek A, Vermeulen JH, Hultquist C.

Chest. 2006 Dec;130(6):1733-43.

PMID:
17166990
18.

Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.

Buhl R, Vogelmeier C.

Curr Med Res Opin. 2007 Aug;23(8):1867-78. Review.

PMID:
17605896
19.

Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.

Braido F, Baiardini I, Compalati E, Bordo A, Canonica GW.

Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):361-74. doi: 10.1097/ACI.0b013e3283489c0e. Review.

PMID:
21659859
20.

Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?

Aubier M, Haughney J, Selroos O, van Schayck OC, Ekström T, Ostinelli J, Buhl R.

Ther Adv Respir Dis. 2011 Oct;5(5):289-98. doi: 10.1177/1753465811407236. Epub 2011 May 17. Erratum in: Ther Adv Respir Dis. 2012 Aug;6(4):247.

PMID:
21586508

Supplemental Content

Support Center